HEADER CHAPERONE 04-AUG-16 5LNF TITLE SOLUTION NMR STRUCTURE OF FARNESYLATED PEX19, C-TERMINAL DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOMAL BIOGENESIS FACTOR 19; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 161-299; COMPND 5 SYNONYM: 33 KDA HOUSEKEEPING PROTEIN,PEROXIN-19,PEROXISOMAL COMPND 6 FARNESYLATED PROTEIN; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PEX19, HK33, PXF, OK/SW-CL.22; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PEX19, FARNESYLATION, POST TRANSLATIONAL MODIFICATION, ALLOSTERY, KEYWDS 2 CHAPERONE EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR L.EMMANOUILIDIS,U.SCHUETZ,K.TRIPSIANES,T.MADL,J.RADKE,R.RUCKTAESCHEL, AUTHOR 2 M.WILMANNS,W.SCHLIEBS,R.ERDMANN,M.SATTLER REVDAT 4 13-NOV-24 5LNF 1 REMARK REVDAT 3 11-SEP-19 5LNF 1 REMARK REVDAT 2 22-MAR-17 5LNF 1 JRNL REVDAT 1 15-MAR-17 5LNF 0 JRNL AUTH L.EMMANOUILIDIS,U.SCHUTZ,K.TRIPSIANES,T.MADL,J.RADKE, JRNL AUTH 2 R.RUCKTASCHEL,M.WILMANNS,W.SCHLIEBS,R.ERDMANN,M.SATTLER JRNL TITL ALLOSTERIC MODULATION OF PEROXISOMAL MEMBRANE PROTEIN JRNL TITL 2 RECOGNITION BY FARNESYLATION OF THE PEROXISOMAL IMPORT JRNL TITL 3 RECEPTOR PEX19. JRNL REF NAT COMMUN V. 8 14635 2017 JRNL REFN ESSN 2041-1723 JRNL PMID 28281558 JRNL DOI 10.1038/NCOMMS14635 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER A. T. ET.AL. REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5LNF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-SEP-16. REMARK 100 THE DEPOSITION ID IS D_1200000358. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 50 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 1 MM {U-1H,13C,15N; FARNESYL REMARK 210 -[1H,12C]} PEX19, 90% H2O/10% D2O; 1 MM {U-2H,12C,15N; LEU-[1H, REMARK 210 13C,15N]; FARNESYL-[1H,12C]} PEX19, 90% H2O/10% D2O; 1 MM {U-2H, REMARK 210 12C,15N; LLE-[1H,13C,15N]; FARNESYL-[1H,12C]} PEX19, 90% H2O/10% REMARK 210 D2O; 1 MM {U-2H,12C,15N; MET-[1H,13CH3,15N]; FARNESYL-[1H,12C]} REMARK 210 PEX19, 90% H2O/10% D2O; 1 MM {U-2H,12C,15N; ILE(DELTA1), REMARK 210 LEU(DELTA),VAL(GAMMA)-[13CH3]; FARNESYL-[1H,12C]} PEX19, 90% H2O/ REMARK 210 10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D HNCA; 3D HNCACB; 3D REMARK 210 CBCA(CO)NH; 3D HCCH-TOCSY; 3D 1H- REMARK 210 13C NOESY; 3D 1H-15N NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 750 MHZ; 900 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 630 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9120 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 CYS A 296 -72.35 -103.97 REMARK 500 1 ILE A 298 -77.26 -81.72 REMARK 500 2 ALA A 291 80.83 63.06 REMARK 500 2 SER A 292 16.46 -145.51 REMARK 500 2 GLN A 295 -147.34 -122.49 REMARK 500 2 CYS A 296 -70.32 -120.61 REMARK 500 2 ILE A 298 -78.98 -76.75 REMARK 500 3 ASP A 163 86.92 56.74 REMARK 500 3 ASN A 170 73.26 -116.73 REMARK 500 3 PRO A 274 102.80 -55.11 REMARK 500 3 LEU A 276 21.80 -77.24 REMARK 500 3 GLN A 295 -144.37 -110.57 REMARK 500 3 CYS A 296 -70.60 -111.42 REMARK 500 3 ILE A 298 -73.35 -85.56 REMARK 500 4 PRO A 274 102.38 -58.47 REMARK 500 4 LEU A 276 30.59 -80.74 REMARK 500 4 GLU A 294 102.56 -56.02 REMARK 500 4 CYS A 296 -72.94 -105.26 REMARK 500 4 ILE A 298 -82.25 -81.28 REMARK 500 5 PRO A 274 108.66 -49.58 REMARK 500 5 ALA A 291 93.41 63.35 REMARK 500 5 SER A 292 27.60 -176.15 REMARK 500 5 CYS A 296 -71.47 -101.51 REMARK 500 5 ILE A 298 -81.37 -79.91 REMARK 500 6 GLU A 164 42.14 -92.32 REMARK 500 6 LEU A 276 30.49 -80.34 REMARK 500 6 GLN A 295 -164.79 -122.09 REMARK 500 6 CYS A 296 -72.59 -110.15 REMARK 500 6 ILE A 298 -73.77 -84.12 REMARK 500 7 GLU A 164 85.34 61.48 REMARK 500 7 GLU A 294 97.46 -64.56 REMARK 500 7 CYS A 296 -72.15 -107.31 REMARK 500 7 ILE A 298 -74.11 -91.05 REMARK 500 8 PRO A 274 105.25 -56.60 REMARK 500 8 SER A 286 48.19 -88.93 REMARK 500 8 PRO A 289 25.61 -74.83 REMARK 500 8 SER A 292 18.64 -148.59 REMARK 500 8 CYS A 296 -70.30 -115.97 REMARK 500 8 ILE A 298 -74.18 -81.56 REMARK 500 9 PRO A 274 109.41 -50.18 REMARK 500 9 LEU A 276 32.48 -78.29 REMARK 500 9 GLN A 295 -160.90 -125.29 REMARK 500 9 CYS A 296 -72.85 -113.47 REMARK 500 9 ILE A 298 -78.01 -74.53 REMARK 500 10 MET A 162 -166.66 65.54 REMARK 500 10 GLU A 168 73.69 59.04 REMARK 500 10 PRO A 274 100.73 -55.90 REMARK 500 10 LEU A 276 31.86 -75.71 REMARK 500 10 GLU A 294 106.37 -56.54 REMARK 500 10 GLN A 295 -167.97 -129.34 REMARK 500 REMARK 500 THIS ENTRY HAS 104 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FAR A 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 34030 RELATED DB: BMRB REMARK 900 SOLUTION NMR STRUCTURE OF FARNESYLATED PEX19, C-TERMINAL DOMAIN DBREF 5LNF A 161 299 UNP P40855 PEX19_HUMAN 161 299 SEQRES 1 A 139 GLY MET ASP GLU GLY ASP GLY GLU GLY ASN ILE LEU PRO SEQRES 2 A 139 ILE MET GLN SER ILE MET GLN ASN LEU LEU SER LYS ASP SEQRES 3 A 139 VAL LEU TYR PRO SER LEU LYS GLU ILE THR GLU LYS TYR SEQRES 4 A 139 PRO GLU TRP LEU GLN SER HIS ARG GLU SER LEU PRO PRO SEQRES 5 A 139 GLU GLN PHE GLU LYS TYR GLN GLU GLN HIS SER VAL MET SEQRES 6 A 139 CYS LYS ILE CYS GLU GLN PHE GLU ALA GLU THR PRO THR SEQRES 7 A 139 ASP SER GLU THR THR GLN LYS ALA ARG PHE GLU MET VAL SEQRES 8 A 139 LEU ASP LEU MET GLN GLN LEU GLN ASP LEU GLY HIS PRO SEQRES 9 A 139 PRO LYS GLU LEU ALA GLY GLU MET PRO PRO GLY LEU ASN SEQRES 10 A 139 PHE ASP LEU ASP ALA LEU ASN LEU SER GLY PRO PRO GLY SEQRES 11 A 139 ALA SER GLY GLU GLN CYS LEU ILE MET HET FAR A 301 40 HETNAM FAR FARNESYL FORMUL 2 FAR C15 H26 HELIX 1 AA1 ILE A 171 LEU A 183 1 13 HELIX 2 AA2 SER A 184 ARG A 207 1 24 HELIX 3 AA3 PRO A 211 ALA A 234 1 24 HELIX 4 AA4 SER A 240 GLY A 262 1 23 HELIX 5 AA5 ASP A 279 ASN A 284 1 6 LINK SG CYS A 296 C1 FAR A 301 1555 1555 1.79 SITE 1 AC1 10 LEU A 183 LEU A 188 LEU A 192 MET A 255 SITE 2 AC1 10 LEU A 258 GLN A 259 PHE A 278 LEU A 283 SITE 3 AC1 10 CYS A 296 ILE A 298 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1